- Home
- FSBC vs CRMD Comparison
FSBC vs CRMD Comparison
Compare FSBC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- CRMD
- Stock Information
- Founded
- FSBC 2002
- CRMD 2006
- Country
- FSBC United States
- CRMD United States
- Employees
- FSBC N/A
- CRMD N/A
- Industry
- FSBC Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- FSBC Finance
- CRMD Health Care
- Exchange
- FSBC Nasdaq
- CRMD Nasdaq
- Market Cap
- FSBC 565.6M
- CRMD 877.5M
- IPO Year
- FSBC 2021
- CRMD 2010
- Fundamental
- Price
- FSBC $30.07
- CRMD $11.28
- Analyst Decision
- FSBC Buy
- CRMD Strong Buy
- Analyst Count
- FSBC 4
- CRMD 7
- Target Price
- FSBC $34.75
- CRMD $17.33
- AVG Volume (30 Days)
- FSBC 55.6K
- CRMD 2.2M
- Earning Date
- FSBC 07-23-2025
- CRMD 08-13-2025
- Dividend Yield
- FSBC 2.64%
- CRMD N/A
- EPS Growth
- FSBC N/A
- CRMD N/A
- EPS
- FSBC 2.27
- CRMD 0.28
- Revenue
- FSBC $124,973,000.00
- CRMD $82,553,827.00
- Revenue This Year
- FSBC $25.86
- CRMD $238.38
- Revenue Next Year
- FSBC $15.15
- CRMD $53.52
- P/E Ratio
- FSBC $13.35
- CRMD $40.46
- Revenue Growth
- FSBC 11.14
- CRMD N/A
- 52 Week Low
- FSBC $22.22
- CRMD $3.61
- 52 Week High
- FSBC $35.13
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- FSBC 64.34
- CRMD 39.54
- Support Level
- FSBC $29.63
- CRMD $11.13
- Resistance Level
- FSBC $30.65
- CRMD $11.86
- Average True Range (ATR)
- FSBC 0.79
- CRMD 0.65
- MACD
- FSBC 0.21
- CRMD -0.34
- Stochastic Oscillator
- FSBC 86.10
- CRMD 3.81
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.